Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 150 results
A minimalist illustration of a mosquito and a blood drop representing malaria diagnostics.

Jul 14, 2026

Noul's miLab MAL highlighted as leading AI malaria diagnostic in Harvard-led international study

Noul's miLab MAL has been recognized as a leading AI-driven diagnostic tool for malaria in a recent review published by a Harvard-led international research team.The study, featured in "npj Digital Medicine," highlights the effectiveness of Noul's miLab MAL in the context of the global malaria diagnostic landscape. Researchers employed a scoping review methodology, examining both traditional diagnostic methods like microscopy and PCR, alongside emerging AI technologies. This comprehensive approa
A microscope slide with a biological sample in a dimly lit lab setting.

Jul 13, 2026

Microscopy Software Market Size to Hit USD 5.24 Billion by 2035

The microscopy software market is projected to grow significantly, reaching USD 5.24 billion by 2035, driven by advancements in artificial intelligence (AI) and machine learning (ML).The global microscopy software market was valued at USD 1.75 billion in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 11.60% from 2026 to 2035. North America is currently the leading region, accounting for 38% of the market share, while the Asia-Pacific region is anticipated to experience
Flat illustration of an MRI scan and brain silhouette

Jul 12, 2026

Viz.ai Partners With Cortechs.ai to Expand AI-Powered Neurodegenerative Disease Care

Viz.ai has announced a strategic partnership with Cortechs.ai to enhance care for neurodegenerative diseases, starting with multiple sclerosis (MS).The collaboration aims to integrate Cortechs.ai's NeuroQuant MS, a quantitative MRI analysis tool, into Viz.ai's Neuro Suite. This integration is set to streamline clinical workflows, allowing healthcare professionals to access critical MRI insights directly within the Viz platform. Such enhancements are expected to facilitate quicker identification
Flat illustration of a tissue sample with an AI brain overlay

Jul 11, 2026

AI in Cancer Diagnostics Market Anticipates Revenue of US$ 2,367.8 Million by 2034

The AI in cancer diagnostics market is poised for significant growth, projected to reach approximately $2.37 billion by 2034, up from $271.1 million in 2024, reflecting a compound annual growth rate (CAGR) of 24.2%.Artificial intelligence is increasingly integral to cancer diagnostics, enhancing early detection and accuracy. AI systems analyze extensive medical data, including imaging and pathology, to uncover patterns indicative of cancer. In medical imaging, AI aids radiologists by pinpointing
MRI machine in a hospital imaging room with a patient and radiologist

Jul 9, 2026

AI-Powered Imaging Diagnostics Market to Reach US$ 9.73 Billion

The AI-powered imaging diagnostics market is projected to grow significantly, reaching an estimated US$9.73 billion by 2033, with a compound annual growth rate (CAGR) of 22.3% from 2025 to 2033. This growth reflects a shift from pilot projects to operational frameworks in hospitals, where AI technologies are increasingly utilized for urgent scan triage and improved diagnostic workflows across various imaging modalities.Recent developments highlight the rapid advancement of AI in imaging diagnost
Flat illustration of a CT scan machine

Jul 9, 2026

AI-Powered Imaging Diagnostics Market Set to Reach USD 9.73

The AI-powered imaging diagnostics market is projected to grow significantly, reaching USD 9.73 billion by 2033, driven largely by advancements in artificial intelligence across various imaging modalities.This market, which was valued at USD 1.97 billion in 2025, is expected to expand at a compound annual growth rate (CAGR) of 22.3% from 2026 to 2033. Key factors contributing to this growth include the rising demand for enhanced diagnostic accuracy and efficiency, as well as the integration of A
Silhouette of coronary plaque and cardiac CT scan

Jul 9, 2026

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

Caristo Diagnostics is set to showcase significant advancements in AI-driven cardiovascular technologies at the upcoming SCCT 2026 Annual Scientific Meeting. Notably, three abstracts nominated for the Young Investigator Award will feature findings from the University of Oxford's ORFAN registry, emphasizing the application of the FAI-Score in both contrast and non-contrast cardiac CT scans.The presentations will explore the enhanced ability of FAI-Score to quantify coronary inflammation, providin
ultrasound transducer and patient monitor silhouettes

Jul 8, 2026

GE HealthCare explores growth in medical imaging and diagnostics

GE HealthCare is strategically enhancing its presence in medical imaging, diagnostics, and patient monitoring, with a focus on providing integrated solutions for hospitals and health systems worldwide.As a prominent player in medical technology, GE HealthCare offers a wide array of imaging and diagnostic equipment designed to streamline clinical workflows and assist healthcare professionals in making informed decisions. The company’s technology is pivotal in various care settings, including radi
Minimalist illustration of a heart with plaque

Jul 8, 2026

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

Caristo Diagnostics is set to present significant advancements in its AI-driven coronary inflammation and plaque analysis technologies at the SCCT 2026 Annual Scientific Meeting.The upcoming conference will showcase findings from the University of Oxford-led ORFAN registry, where three out of six nominated abstracts for the SCCT Young Investigator Award utilize Caristo's technologies. Notably, this includes the application of the Fat Attenuation Index (FAI) Score on non-contrast cardiac CT for t
A patient undergoing a cardiac CT scan in a clinical setting.

Jul 7, 2026

Catalyst MedTech Announces Channel Partnership with APQ

Catalyst MedTech has announced a strategic partnership with APQ Health to enhance access to advanced cardiac CT angiography (CCTA) visualization and plaque analysis services. This collaboration aims to address the growing demand for early detection and personalized risk assessment in coronary artery disease management.The partnership comes at a time when healthcare providers are increasingly adopting cardiac CT as a primary diagnostic tool for chest pain. However, many face challenges such as li
A bottle of ultrasound gel and probe in a clinical setting

Jul 7, 2026

AI in Ultrasound Imaging Market to Reach $2.23 Billion by 2030 with Growing Demand for Point-of-Care Diagnostics

The AI in ultrasound imaging market is on a significant growth trajectory, projected to increase from $1.28 billion in 2025 to $2.23 billion by 2030, reflecting a compound annual growth rate of 11.8%. This expansion is largely fueled by the rising demand for point-of-care diagnostics, advancements in machine learning, and the increasing incidence of cancer, which necessitates improved diagnostic capabilities for better patient outcomes.Key players in the industry, such as Siemens Healthineers an
A minimalist representation of clinical data analysis with an upward arrow.

Jul 6, 2026

Praise Ifenna Okwuba on the Future of AI-Powered Diagnostics in Healthcare

Praise Ifenna Okwuba, a data scientist at the forefront of AI in healthcare, highlights the transformative potential of AI-powered diagnostics in enhancing diagnostic accuracy and patient care.Okwuba points out that as artificial intelligence gains traction in healthcare, machine learning and advanced analytics are emerging as critical tools to tackle persistent challenges in the sector. He emphasizes that AI's ability to process vast amounts of clinical data can lead to significant improvements